Kerrie B. Bouker

1.7k total citations
27 papers, 1.4k citations indexed

About

Kerrie B. Bouker is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Kerrie B. Bouker has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 15 papers in Genetics and 13 papers in Molecular Biology. Recurrent topics in Kerrie B. Bouker's work include Estrogen and related hormone effects (11 papers), Cytokine Signaling Pathways and Interactions (6 papers) and Cancer Risks and Factors (5 papers). Kerrie B. Bouker is often cited by papers focused on Estrogen and related hormone effects (11 papers), Cytokine Signaling Pathways and Interactions (6 papers) and Cancer Risks and Factors (5 papers). Kerrie B. Bouker collaborates with scholars based in United States, Finland and Switzerland. Kerrie B. Bouker's co-authors include Robert Clarke, Todd C. Skaar, Leena Hilakivi‐Clarke, Leena Hilakivi‐Clarke, Kerry O’Brien, Yuelin J. Zhu, Zhiping Gu, Richard Y. Lee, Yue Wang and Bianca Gomez and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Kerrie B. Bouker

27 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kerrie B. Bouker United States 17 742 481 455 281 198 27 1.4k
Christoforos Thomas United States 18 665 0.9× 474 1.0× 491 1.1× 254 0.9× 88 0.4× 30 1.3k
Debra A. Tonetti United States 26 935 1.3× 662 1.4× 561 1.2× 245 0.9× 111 0.6× 57 1.7k
Yayun Liang United States 23 749 1.0× 370 0.8× 369 0.8× 355 1.3× 85 0.4× 50 1.3k
Joan Lewis-Wambi United States 20 631 0.9× 424 0.9× 471 1.0× 323 1.1× 82 0.4× 31 1.3k
Sung Hoo Jung South Korea 24 772 1.0× 392 0.8× 171 0.4× 310 1.1× 211 1.1× 86 1.5k
Russell D. Klein United States 20 524 0.7× 229 0.5× 290 0.6× 246 0.9× 123 0.6× 24 1.1k
Valérie Hindie France 10 877 1.2× 300 0.6× 215 0.5× 134 0.5× 109 0.6× 12 1.3k
Lih‐Ching Hsu Taiwan 21 1.0k 1.4× 371 0.8× 263 0.6× 231 0.8× 85 0.4× 62 1.4k
Weigang Tong United States 18 632 0.9× 270 0.6× 194 0.4× 198 0.7× 78 0.4× 30 1.4k
Elise F. Saunier United States 15 675 0.9× 313 0.7× 215 0.5× 235 0.8× 79 0.4× 19 1.1k

Countries citing papers authored by Kerrie B. Bouker

Since Specialization
Citations

This map shows the geographic impact of Kerrie B. Bouker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerrie B. Bouker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerrie B. Bouker more than expected).

Fields of papers citing papers by Kerrie B. Bouker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerrie B. Bouker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerrie B. Bouker. The network helps show where Kerrie B. Bouker may publish in the future.

Co-authorship network of co-authors of Kerrie B. Bouker

This figure shows the co-authorship network connecting the top 25 collaborators of Kerrie B. Bouker. A scholar is included among the top collaborators of Kerrie B. Bouker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerrie B. Bouker. Kerrie B. Bouker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weinberg, Benjamin A., Martin Gutierrez, Anteneh Tesfaye, et al.. (2023). Phase II trial of BXCL701 and pembrolizumab in patients with metastatic pancreatic ductal adenocarcinoma (EXPEL-PANC).. Journal of Clinical Oncology. 41(16_suppl). TPS4194–TPS4194. 1 indexed citations
2.
Kwon, Juntae, Haiyang Wang, Kerrie B. Bouker, et al.. (2022). USP13 promotes development and metastasis of high-grade serous ovarian carcinoma in a novel mouse model. Oncogene. 41(13). 1974–1985. 12 indexed citations
3.
Kwon, Juntae, Min Soon Cho, Yifan Sun, et al.. (2021). Targeting DDX3X Triggers Antitumor Immunity via a dsRNA-Mediated Tumor-Intrinsic Type I Interferon Response. Cancer Research. 81(13). 3607–3620. 40 indexed citations
4.
Sumis, Allison, Katherine L. Cook, Rong Hu, et al.. (2016). Social isolation induces autophagy in the mouse mammary gland: link to increased mammary cancer risk. Endocrine Related Cancer. 23(10). 839–856. 17 indexed citations
5.
Hilakivi‐Clarke, Leena, Anni Wärri, Kerrie B. Bouker, et al.. (2016). Effects of In Utero Exposure to Ethinyl Estradiol on Tamoxifen Resistance and Breast Cancer Recurrence in a Preclinical Model. JNCI Journal of the National Cancer Institute. 109(1). djw188–djw188. 25 indexed citations
6.
Kang, Keunsoo, Edgar S. Díaz‐Cruz, Margaret L. Axelrod, et al.. (2014). Comparison of tamoxifen and letrozole response in mammary preneoplasia of ER and aromatase overexpressing mice defines an immune-associated gene signature linked to tamoxifen resistance. Carcinogenesis. 36(1). 122–132. 16 indexed citations
7.
Aiyer, Harini S., Kerrie B. Bouker, Katherine L. Cook, et al.. (2012). Interaction of dietary polyphenols with molecular signaling pathways of antiestrogen resistance: possible role in breast cancer recurrence. Hormone Molecular Biology and Clinical Investigation. 9(2). 127–141. 8 indexed citations
8.
Bouker, Kerrie B., Yue Wang, Jianhua Xuan, & Robert Clarke. (2012). Antiestrogen resistance and the application of systems biology. Drug Discovery Today Disease Mechanisms. 9(1-2). e11–e17. 2 indexed citations
9.
Bouker, Kerrie B., Todd C. Skaar, David S. Harburger, et al.. (2007). The A4396G polymorphism in interferon regulatory factor 1 is frequently expressed in breast cancer cell lines. Cancer Genetics and Cytogenetics. 175(1). 61–64. 12 indexed citations
10.
Bouker, Kerrie B., Todd C. Skaar, Rebecca B. Riggins, et al.. (2005). Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis. Carcinogenesis. 26(9). 1527–1535. 107 indexed citations
11.
Marshall, John L., Huanwen Chen, Dongxiao Yang, et al.. (2004). A phase I trial of a Bcl-2 antisense (G3139) and weekly docetaxel in patients with advanced breast cancer and other solid tumors. Annals of Oncology. 15(8). 1274–1283. 50 indexed citations
12.
Bouker, Kerrie B., Todd C. Skaar, David Fernández, et al.. (2004). Interferon Regulatory Factor-1 Mediates the Proapoptotic but Not Cell Cycle Arrest Effects of the Steroidal Antiestrogen ICI 182,780 (Faslodex, Fulvestrant). Cancer Research. 64(11). 4030–4039. 58 indexed citations
13.
Clarke, Robert, Minetta C. Liu, Kerrie B. Bouker, et al.. (2003). Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling. Oncogene. 22(47). 7316–7339. 378 indexed citations
14.
Hilakivi‐Clarke, Leena, et al.. (2002). Do estrogens always increase breast cancer risk?. The Journal of Steroid Biochemistry and Molecular Biology. 80(2). 163–174. 51 indexed citations
15.
Oberst, Michael D., et al.. (2002). The RhoA-binding protein, Rhophilin-2, Regulates Actin Cytoskeleton Organization. Journal of Biological Chemistry. 277(46). 43924–43932. 70 indexed citations
16.
Hilakivi‐Clarke, Leena, et al.. (2001). Maternal and Prepubertal Diet, Mammary Development and Breast Cancer Risk. Journal of Nutrition. 131(1). 154S–157S. 53 indexed citations
17.
Clarke, Robert, et al.. (2001). Molecular and pharmacological aspects of antiestrogen resistance. The Journal of Steroid Biochemistry and Molecular Biology. 76(1-5). 71–84. 116 indexed citations
18.
Chang, Esther H., Kathleen F. Pirollo, & Kerrie B. Bouker. (2000). Tp53 gene therapy: a key to modulating resistance to anticancer therapies?. Molecular Medicine Today. 6(9). 358–365. 21 indexed citations
19.
Bouker, Kerrie B. & Leena Hilakivi‐Clarke. (2000). Genistein: does it prevent or promote breast cancer?. Environmental Health Perspectives. 108(8). 701–708. 132 indexed citations
20.
Pirollo, Kathleen F., Kerrie B. Bouker, & Esther H. Chang. (2000). Does p53 status influence tumor response to anticancer therapies?. Anti-Cancer Drugs. 11(6). 419–432. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christoforos Thomas Breakdown of academic impact, for papers by Debra A. Tonetti Breakdown of academic impact, for papers by Yayun Liang Breakdown of academic impact, for papers by Joan Lewis-Wambi Breakdown of academic impact, for papers by Sung Hoo Jung Breakdown of academic impact, for papers by Russell D. Klein Breakdown of academic impact, for papers by Valérie Hindie Breakdown of academic impact, for papers by Lih‐Ching Hsu Breakdown of academic impact, for papers by Weigang Tong Breakdown of academic impact, for papers by Elise F. Saunier
Rankless by CCL
2026